RECOMMENDATION(S):
Approve and authorize the Purchasing Agent, on behalf of the Health Services Department, to execute a Purchase Order with Priority Healthcare Corporation in an amount not to exceed $900,000, for the hormone implant Nexplanon to be used at the Contra Costa Regional Medical Center (CCRMC), for the period from December 1, 2017 through November 30, 2018.
FISCAL IMPACT:
Upon approval, this expenditure will be 100% funded by Hospital Enterprise Fund I.
BACKGROUND:
Priority Healthcare Corporation is a pharmaceutical company that provides CCRMC and Health Centers with the hormone implant Nexplanon to be used in the Obstetrics/Gynecology Unit.
CONSEQUENCE OF NEGATIVE ACTION:
If this Purchase Order is not approved, CCRMC and Health Centers will not be able to purchase Nexplanon for patients.
|